231 related articles for article (PubMed ID: 11565082)
1. Prevention of infection caused by Pneumocystis carinii in transplant recipients.
Fishman JA
Clin Infect Dis; 2001 Oct; 33(8):1397-405. PubMed ID: 11565082
[TBL] [Abstract][Full Text] [Related]
2. A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation.
Colby C; McAfee S; Sackstein R; Finkelstein D; Fishman J; Spitzer T
Bone Marrow Transplant; 1999 Oct; 24(8):897-902. PubMed ID: 10516703
[TBL] [Abstract][Full Text] [Related]
3. [Pneumocystis carinii pneumonia in patients with a solid organ transplant: a report of 5 cases].
Ruiz Ruiz J; Yebra Bango M; Fernández Fernández J; Alonso Pulpón L; Cuervas-Mons Martínez V; Besada Estévez E; Daza Pérez RM
Rev Clin Esp; 1997 Jan; 197(1):31-4. PubMed ID: 9102669
[TBL] [Abstract][Full Text] [Related]
4. Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection.
Hughes WT; Dankner WM; Yogev R; Huang S; Paul ME; Flores MA; Kline MW; Wei LJ;
Clin Infect Dis; 2005 Jan; 40(1):136-45. PubMed ID: 15614703
[TBL] [Abstract][Full Text] [Related]
5. Intermittent oral trimethoprim/sulfamethoxazole on two non-consecutive days per week is effective as Pneumocystis jiroveci pneumonia prophylaxis in pediatric patients receiving chemotherapy or hematopoietic stem cell transplantation.
Ohata Y; Ohta H; Hashii Y; Tokimasa S; Ozono K; Hara J
Pediatr Blood Cancer; 2009 Jan; 52(1):142-4. PubMed ID: 18819150
[TBL] [Abstract][Full Text] [Related]
6. [New aspects of epidemiology and treatment of Pneumocystis carinii infection].
Powierska-Czarny J; Gospodarek E; Czerwionka-Szaflarska M
Pol Merkur Lekarski; 2004 Nov; 17(101):534-7. PubMed ID: 15754652
[TBL] [Abstract][Full Text] [Related]
7. Prophylaxis strategies for solid-organ transplantation.
Soave R
Clin Infect Dis; 2001 Jul; 33 Suppl 1():S26-31. PubMed ID: 11389519
[TBL] [Abstract][Full Text] [Related]
8. Recurrent Pneumocystis carinii colonization in a heart-lung transplant recipient on long-term trimethoprim-sulfamethoxazole prophylaxis.
Faul JL; Akindipe OA; Berry GJ; Doyle RL; Theodore J
J Heart Lung Transplant; 1999 Apr; 18(4):384-7. PubMed ID: 10226906
[TBL] [Abstract][Full Text] [Related]
9. High rates of Pneumocystis carinii pneumonia in allogeneic blood and marrow transplant recipients receiving dapsone prophylaxis.
Souza JP; Boeckh M; Gooley TA; Flowers ME; Crawford SW
Clin Infect Dis; 1999 Dec; 29(6):1467-71. PubMed ID: 10585797
[TBL] [Abstract][Full Text] [Related]
10. Prophylaxis with trimethoprim-sulfamethoxazole for human immunodeficiency virus-infected patients: impact on risk for infectious diseases.
Dworkin MS; Williamson J; Jones JL; Kaplan JE;
Clin Infect Dis; 2001 Aug; 33(3):393-8. PubMed ID: 11438910
[TBL] [Abstract][Full Text] [Related]
11. Pneumocystis carinii pneumonia prophylaxis with atovaquone in trimethoprim-sulfamethoxazole-intolerant orthotopic liver transplant patients: a preliminary study.
Meyers B; Borrego F; Papanicolaou G
Liver Transpl; 2001 Aug; 7(8):750-1. PubMed ID: 11510024
[TBL] [Abstract][Full Text] [Related]
12. Pneumocystis jiroveci in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
Fishman JA; Gans H;
Clin Transplant; 2019 Sep; 33(9):e13587. PubMed ID: 31077616
[TBL] [Abstract][Full Text] [Related]
13. Lower risk of urinary tract infection with low-dose trimethoprim/sulfamethoxazole compared to dapsone prophylaxis in older renal transplant patients on a rapid steroid-withdrawal immunosuppression regimen.
Giullian JA; Cavanaugh K; Schaefer H
Clin Transplant; 2010; 24(5):636-42. PubMed ID: 19925478
[TBL] [Abstract][Full Text] [Related]
14. Viral infections in transplant recipients.
Razonable RR; Eid AJ
Minerva Med; 2009 Dec; 100(6):479-501. PubMed ID: 20010483
[TBL] [Abstract][Full Text] [Related]
15. Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients.
Dykewicz CA; ; ;
Clin Infect Dis; 2001 Jul; 33(2):139-44. PubMed ID: 11418871
[TBL] [Abstract][Full Text] [Related]
16. Challenges in the diagnosis and management of Nocardia infections in lung transplant recipients.
Poonyagariyagorn HK; Gershman A; Avery R; Minai O; Blazey H; Asamoto K; Alster J; Murthy S; Mehta A; Pettersson G; Mason DP; Budev M
Transpl Infect Dis; 2008 Dec; 10(6):403-8. PubMed ID: 18823356
[TBL] [Abstract][Full Text] [Related]
17. Pneumocystis carinii and parasitic infections in transplantation.
Fishman JA
Infect Dis Clin North Am; 1995 Dec; 9(4):1005-44. PubMed ID: 8747777
[TBL] [Abstract][Full Text] [Related]
18. Successful toxoplasmosis prophylaxis after orthotopic cardiac transplantation with trimethoprim-sulfamethoxazole.
Baden LR; Katz JT; Franck L; Tsang S; Hall M; Rubin RH; Jarcho J
Transplantation; 2003 Feb; 75(3):339-43. PubMed ID: 12589155
[TBL] [Abstract][Full Text] [Related]
19. Ineffectiveness of trimethoprim-sulfamethoxazole prophylaxis and the importance of bacterial and viral coinfections in African children with Pneumocystis carinii pneumonia.
Madhi SA; Cutland C; Ismail K; O'Reilly C; Mancha A; Klugman KP
Clin Infect Dis; 2002 Nov; 35(9):1120-6. PubMed ID: 12384847
[TBL] [Abstract][Full Text] [Related]
20. Successful intermittent prophylaxis with trimethoprim/sulfamethoxazole 2 days per week for Pneumocystis carinii (jiroveci) pneumonia in pediatric oncology patients.
Lindemulder S; Albano E
Pediatrics; 2007 Jul; 120(1):e47-51. PubMed ID: 17606548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
